DCwire® Micro Guidewire Receives FDA 510(k) Clearance, Marking a Key Milestone in Peijia Medical's Global Expansion

Core Insights - Peijia Medical has received FDA 510(k) clearance for its DCwire® Micro Guidewire, marking a significant milestone in its global expansion strategy [1][2] - This is the first FDA-cleared product in Peijia Medical's portfolio, highlighting the company's commitment to innovation in neurointerventional medical devices [2][3] - The clearance enables Peijia Medical to enter the U.S. market, laying a strong foundation for the international commercialization of its neurointerventional portfolio [3] Company Overview - Peijia Medical, established in 2012 and headquartered in Suzhou, China, focuses on the high-growth interventional procedural medical device market [4] - The company aims to become a world-renowned medical device platform, providing comprehensive treatment solutions for structural heart and neurovascular diseases [4] - Peijia Medical currently has four TAVR systems and nearly twenty neurointerventional devices commercialized in China, with various innovative product candidates at different stages of development [4]